The global Radiotherapy Market reached USD 7.1 billion in 2024 and is projected to grow to USD 9.9 billion by 2033, at a CAGR of 3.8%. Rapidly rising cancer incidence, advanced tumor targeting, and expanding healthcare spending are fueling its growth. Enhanced treatment precision from technological innovations and growing market awareness continue to drive demand for this non-invasive cancer therapy.
STUDY ASSUMPTION YEARS:
BASE YEAR: 2024
HISTORICAL YEAR: 2019–2024
FORECAST YEAR: 2025–2033
Radiotherapy Market Key Takeaways
USD 7.1 bn in 2024 - USD 9.9 bn by 2033 (CAGR 3.8%), highlighting sustained upward market momentum
North America leads, capturing over 35.8% of global market share in 2024.
By Type: Major segments include External Beam Radiation Therapy, Internal/Brachytherapy, and Systemic Radiation Therapy.
By Application: Utilized across skin, head & neck, breast, prostate, cervical, lung cancers, and more.
By End User: Services delivered via hospitals, cancer research institutes, and ambulatory & radiotherapy centers.
Growth drivers: Increasing cancer cases, technological progress, government policies, and rising healthcare awareness are fueling market expansion.
Market Growth Factors
The radiotherapy market is primarily driven by the continuous rise in global cancer incidence, which has significantly increased the demand for effective and scalable treatment solutions. As cancer remains one of the leading causes of mortality worldwide, healthcare systems are expanding oncology infrastructure to manage the growing patient burden. Radiotherapy is increasingly adopted across early-stage, localized, and palliative cancer treatments due to its ability to destroy cancerous cells while preserving surrounding healthy tissue. The growing prevalence of breast, lung, prostate, and colorectal cancers has further strengthened radiotherapy utilization. Additionally, aging populations in developed and emerging economies are contributing to higher cancer diagnosis rates, sustaining long-term demand for radiotherapy equipment, software, and related services across hospitals and cancer care centers.
Technological innovation is a major growth catalyst for the radiotherapy market, as continuous advancements are improving treatment precision, safety, and clinical outcomes. Modern radiotherapy systems now incorporate advanced imaging, artificial intelligence–driven planning, and real-time tumor tracking, enabling higher targeting accuracy and reduced damage to surrounding tissues. Techniques such as intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic radiosurgery are increasingly replacing conventional approaches. These innovations enhance patient comfort, reduce treatment sessions, and improve survival rates, making radiotherapy a preferred non-invasive option. As healthcare providers prioritize advanced oncology solutions, investments in next-generation radiotherapy systems are increasing, supporting steady market expansion globally.
Increasing healthcare spending, particularly in oncology infrastructure, is significantly supporting the growth of the radiotherapy market. Governments and private healthcare providers are investing in advanced cancer treatment technologies to improve access, quality of care, and patient outcomes. Alongside rising expenditure, awareness of the benefits of radiotherapy as a non-invasive and cost-effective alternative to cancer treatment is expanding among patients and clinicians. Compared to surgical interventions, radiotherapy offers reduced recovery time, lower procedural risks, and broader applicability across cancer types. This growing awareness, combined with improved reimbursement policies and expanding cancer treatment facilities, is accelerating adoption across both developed and emerging markets, reinforcing the long-term growth outlook of the radiotherapy industry.
Request for a sample copy of this report:
https://www.imarcgroup.com/radiotherapy-market/requestsample
Market Segmentation
Breakdown by Type:
External Beam Radiation Therapy
Internal Radiation Therapy / Brachytherapy
Systemic Radiation Therapy
Breakdown by Application:
Skin and Lip Cancer
Head and Neck Cancer
Breast Cancer
Prostate Cancer
Cervical Cancer
Lung Cancer
Others
Breakdown by End User:
Hospitals
Cancer Research Institutes
Ambulatory and Radiotherapy Centers
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Regional Insights
North America leads the global radiotherapy market, holding over 35.8% share in 2024, driven by advanced healthcare infrastructure, favorable reimbursement policies, and early technology adoption. Strong awareness and high cancer prevalence have made the region a consistent growth engine for global radiotherapy.
Recent Developments & News
The latest innovations in the radiotherapy market reflect a clear trend toward precision and minimally invasive solutions. Advanced technologies like proton therapy and stereotactic radiosurgery are being increasingly adopted, minimizing damage to healthy tissue. Artificial intelligence is also enhancing treatment planning and delivery accuracy. Additionally, strategic collaborations between healthcare providers and tech firms are accelerating the development of personalized oncology solutions, further broadening access to state-of-the-art radiotherapy.
Key Players
Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health), Siemens Healthineers AG (Siemens AG), etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=4413&flag=E
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)
